Hemex, Inc.

Buffalo, NY 14209

SBIR Award Summary

Total Number of Awards 7
Total Value of Awards $0.0
First Award Date 09/15/87
Most Recent Award Date 08/01/94

Key Personnel

Last Name Name Awards Contact
Ambrus Clara M Ambrus 7

7 Awards Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 08/01/94 - 10/31/95

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 08/01/93 - 07/31/94

The magnitude of lead intoxication in our country and the problem with its treatment have created a medical emergency; treatment requires hospitalization, available chelators have serious side effects, and cost of using them is astronomical. We have developed a novel approach to detoxification, a device with immobilized chelators, for extracorp...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/30/91 - 02/28/92

DESCRIPTION (Investigator's Abstract): The principal aim of the proposal in this Phase I application is to develop a device with immobilized chelator of clinical capacity, for removal of excess iron from patients with iron overload. Dr. Ambrus and her colleagues have developed such a device, using polysulfon hollow fiber cartridges with immobi...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/01/91 - 02/29/92

Recent reports estimate the number of children with lead intoxication at 230,000, the number of industrial workers with lead poisoning at 530,000. These number create a medical problem of alarming magnitude, because treatment with available chelators has serious side-effects. Even the chelator-lead complexes that for in the blood during treatme...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 01/01/90 - 12/31/90

Desferrioxamine (DFO) given intravenously for treatment of Aluminum (Al) intoxication is highly toxic itself. To bypass toxicity we have immobilized DFO into a hollow fiber device for the extracorporeal removal of Al from blood. Such a device (similar to a hemodialysis cartridge) is a novel approach to detoxification with unique advantages: (...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 01/01/89 - 12/31/89

Desferrioxamine (DFO) given intravenously for treatment of Aluminum (Al) intoxication is highly toxic itself. To bypass toxicity we have immobilized DFO into a hollow fiber device for the extracorporeal removal of Al from blood. Such a device (similar to a hemodialysis cartridge) is a novel approach to detoxification with unique advantages: (...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/15/87 - 03/14/88

We have developed a hollow fiber device with immobilized chelators for the extracorporeal removal of toxic metals from blood, in specific Aluminum (Al). This device (similar to a hemodialysis cartridge) is a novel approach to detoxification, with unique advantages over existing treatments: (1) The immobilized chelator does not enter the blood...